NRx Pharmaceuticals appoints Dr. Dennis McBride to Board of Directors

NRX Pharmaceuticals, Inc.

Dr. Dennis McBride appointed to Board, effective June 13, 2024.
Bringing neuroscience, IT, and medical technology expertise from DARPA, Navy, and academia.
Serves as research professor at Virginia Tech; former Director of Acquisition and Innovation Research Center for DoD.
Has experience in CNS-focused digital therapeutics with NRx founders.
No related party transactions or arrangements were disclosed in connection with the appointment.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Dennis McBride

member of the Board of Directors

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2024-06-13
Filed: June 20, 2024, 7:59 PM ET

On June 13, 2024, NRx Pharmaceuticals, Inc. (the “ Company ”) appointed Dr. Dennis McBride to serve as a member of the Board of Directors of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dr. Dennis McBride was appointed as member of the Board of Directors at NRX Pharmaceuticals, Inc..

Action: appointed
Role: member of the Board of Directors

Exact text from the filing

On June 13, 2024, NRx Pharmaceuticals, Inc. (the “ Company ”) appointed Dr. Dennis McBride to serve as a member of the Board of Directors of the Company.

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-24-009369

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.